Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

247.35
Delayed Data
As of Feb 17
 +0.42 / +0.17%
Today’s Change
184.50
Today|||52-Week Range
301.32
+17.78%
Year-to-Date
AGN Regular Dividend: AGN will begin trading ex-dividend on 02/24/17 with a $0.70 dividend payable to shareholders of record as of 02/28/17.

Today’s Trading

Previous close246.93
Today’s open246.13
Day’s range245.67 - 248.29
Volume2,494,568
Average volume (3 months)4,785,197
Market cap$92.8B
Dividend yield1.13%
Data as of 4:03pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+281.42%
Earnings growth (this year)+18.79%
Earnings growth (next 5 years)+11.50%
Revenue growth (last year)-3.32%
P/E ratioNM
Price/Sales5.55
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CELGCelgene+2.50+2.11%
BMYBristol-Myers Squibb+0.31+0.57%
LLYEli Lilly and Co+0.35+0.44%
ABBVAbbVie+0.29+0.47%
Data as of 5:17pm ET, 02/17/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)$3.40
Annual revenue (last year)$14.6B
Annual profit (last year)$15.0B
Net profit margin-6.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts


Search for Jobs